nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CACNA1G—Nicotine Activity on Chromaffin Cells—CHRNB4—nicotine dependence	0.331	0.34	CbGpPWpGaD
Trimethadione—CACNA1G—Nicotine Activity on Chromaffin Cells—CHRNA3—nicotine dependence	0.251	0.258	CbGpPWpGaD
Trimethadione—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.04	0.0411	CbGpPWpGaD
Trimethadione—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0346	0.0355	CbGpPWpGaD
Trimethadione—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0308	0.0317	CbGpPWpGaD
Trimethadione—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0281	0.0289	CbGpPWpGaD
Trimethadione—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.0248	0.0255	CbGpPWpGaD
Trimethadione—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.0214	0.022	CbGpPWpGaD
Trimethadione—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.0191	0.0196	CbGpPWpGaD
Trimethadione—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.0174	0.0179	CbGpPWpGaD
Trimethadione—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.0115	0.0118	CbGpPWpGaD
Trimethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0103	0.0106	CbGpPWpGaD
Trimethadione—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0102	0.0104	CbGpPWpGaD
Trimethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0089	0.00914	CbGpPWpGaD
Trimethadione—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00878	0.00902	CbGpPWpGaD
Trimethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00834	0.00857	CbGpPWpGaD
Trimethadione—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00794	0.00815	CbGpPWpGaD
Trimethadione—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00784	0.00805	CbGpPWpGaD
Trimethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00724	0.00744	CbGpPWpGaD
Trimethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00721	0.00741	CbGpPWpGaD
Trimethadione—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00715	0.00734	CbGpPWpGaD
Trimethadione—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00644	0.00661	CbGpPWpGaD
Trimethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00587	0.00603	CbGpPWpGaD
Trimethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00477	0.0049	CbGpPWpGaD
Trimethadione—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00471	0.00484	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0047	0.00483	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.00443	0.00455	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00437	0.00449	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00406	0.00417	CbGpPWpGaD
Trimethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00387	0.00398	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00383	0.00393	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00378	0.00388	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00363	0.00373	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00342	0.00351	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00337	0.00346	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00331	0.0034	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00312	0.0032	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00307	0.00316	CbGpPWpGaD
Trimethadione—Photophobia—Varenicline—nicotine dependence	0.0026	0.099	CcSEcCtD
Trimethadione—Lymphadenopathy—Varenicline—nicotine dependence	0.00236	0.0898	CcSEcCtD
Trimethadione—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00218	0.00224	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00206	0.00211	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00203	0.00208	CbGpPWpGaD
Trimethadione—Irritability—Varenicline—nicotine dependence	0.00192	0.0731	CcSEcCtD
Trimethadione—Epistaxis—Varenicline—nicotine dependence	0.00146	0.0557	CcSEcCtD
Trimethadione—Erythema multiforme—Varenicline—nicotine dependence	0.00132	0.0501	CcSEcCtD
Trimethadione—Ill-defined disorder—Varenicline—nicotine dependence	0.00112	0.0428	CcSEcCtD
Trimethadione—Malaise—Varenicline—nicotine dependence	0.00109	0.0416	CcSEcCtD
Trimethadione—Vertigo—Varenicline—nicotine dependence	0.00109	0.0414	CcSEcCtD
Trimethadione—Discomfort—Varenicline—nicotine dependence	0.00102	0.0388	CcSEcCtD
Trimethadione—Thrombocytopenia—Varenicline—nicotine dependence	0.000969	0.0369	CcSEcCtD
Trimethadione—Anorexia—Varenicline—nicotine dependence	0.000943	0.0359	CcSEcCtD
Trimethadione—Insomnia—Varenicline—nicotine dependence	0.000895	0.034	CcSEcCtD
Trimethadione—Somnolence—Varenicline—nicotine dependence	0.00088	0.0335	CcSEcCtD
Trimethadione—Decreased appetite—Varenicline—nicotine dependence	0.00086	0.0327	CcSEcCtD
Trimethadione—Fatigue—Varenicline—nicotine dependence	0.000853	0.0324	CcSEcCtD
Trimethadione—Feeling abnormal—Varenicline—nicotine dependence	0.000815	0.031	CcSEcCtD
Trimethadione—Gastrointestinal pain—Varenicline—nicotine dependence	0.000809	0.0308	CcSEcCtD
Trimethadione—Abdominal pain—Varenicline—nicotine dependence	0.000782	0.0298	CcSEcCtD
Trimethadione—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000758	0.000778	CbGpPWpGaD
Trimethadione—Asthenia—Varenicline—nicotine dependence	0.00071	0.027	CcSEcCtD
Trimethadione—Pruritus—Varenicline—nicotine dependence	0.0007	0.0266	CcSEcCtD
Trimethadione—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000655	0.000673	CbGpPWpGaD
Trimethadione—Vomiting—Varenicline—nicotine dependence	0.000629	0.0239	CcSEcCtD
Trimethadione—Rash—Varenicline—nicotine dependence	0.000624	0.0237	CcSEcCtD
Trimethadione—Dermatitis—Varenicline—nicotine dependence	0.000623	0.0237	CcSEcCtD
Trimethadione—Headache—Varenicline—nicotine dependence	0.00062	0.0236	CcSEcCtD
Trimethadione—Nausea—Varenicline—nicotine dependence	0.000588	0.0224	CcSEcCtD
Trimethadione—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000585	0.000601	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000533	0.000548	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000352	0.000361	CbGpPWpGaD
